GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medical Marijuana Inc (OTCPK:MJNA) » Definitions » Debt-to-Asset

MJNA (Medical Marijuana) Debt-to-Asset : 0.05 (As of Dec. 2017)


View and export this data going back to 2011. Start your Free Trial

What is Medical Marijuana Debt-to-Asset?

Medical Marijuana's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2017 was $1.41 Mil. Medical Marijuana's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2017 was $13.43 Mil. Medical Marijuana's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2017 was $274.84 Mil. Medical Marijuana's debt to asset for the quarter that ended in Dec. 2017 was 0.05.


Medical Marijuana Debt-to-Asset Historical Data

The historical data trend for Medical Marijuana's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medical Marijuana Debt-to-Asset Chart

Medical Marijuana Annual Data
Trend Dec09 Dec10 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Debt-to-Asset
Get a 7-Day Free Trial 0.03 0.16 - 0.03 0.05

Medical Marijuana Semi-Annual Data
Dec09 Dec10 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Debt-to-Asset Get a 7-Day Free Trial 0.03 0.16 - 0.03 0.05

Competitive Comparison of Medical Marijuana's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Medical Marijuana's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medical Marijuana's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medical Marijuana's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Medical Marijuana's Debt-to-Asset falls into.



Medical Marijuana Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Medical Marijuana's Debt-to-Asset for the fiscal year that ended in Dec. 2017 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(1.41 + 13.432) / 274.838
=0.05

Medical Marijuana's Debt-to-Asset for the quarter that ended in Dec. 2017 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(1.41 + 13.432) / 274.838
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medical Marijuana  (OTCPK:MJNA) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Medical Marijuana Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Medical Marijuana's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Medical Marijuana Business Description

Traded in Other Exchanges
N/A
Address
2384 La Mirada Drive, Vista, CA, USA, 92081
Medical Marijuana Inc is engaged in the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol and other products containing CBD-rich hemp oil. The company's products are used by pharmaceutical, nutraceutical, and cosmeceutical industries. Some of its products are CBD Capsules, CBD Tinctures, Vaporizers, and Hemp foods among others.

Medical Marijuana Headlines

From GuruFocus